ZipRecruiter

Log In

1

Freelance Biotech Investor Relations Jobs (NOW HIRING)

Q32 Bio Inc.

$170 - $230/hr

We are a clinical-stage biotechnology company advancing a potentiallytransformative therapy for alopecia areata, with a bold science-first approach and a pipeline built to make alasting difference ...

previous pagenext page

Showing results 21-40

All Jobsfreelance JobsFinance and Insurance JobsFinancial Services JobsInvestor Relations Associate JobsFreelance Biotech Investor Relations Jobs

Freelance Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do freelance biotech investor relations jobs pay per year?

As of Sep 6, 2026, the average yearly pay for freelance biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What is a freelance biotech investor relations professional?

Freelance biotech investor relations professionals are independent specialists who help biotechnology companies communicate with investors, analysts, and the financial community. They work on a contract basis rather than as full-time employees, providing expertise in preparing press releases, organizing investor meetings, and crafting financial reports. Their role is crucial for building investor confidence, explaining complex scientific concepts in accessible language, and ensuring compliance with financial regulations. By working freelance, they offer flexibility and specialized support to growing or resource-limited biotech firms.

What are the key skills and qualifications needed to thrive as a freelance biotech investor relations professional?

To thrive as a Freelance Biotech Investor Relations specialist, you need a solid understanding of biotechnology, financial markets, and investor communications, often backed by a degree in life sciences, finance, or communications. Familiarity with investor relations management platforms, financial reporting tools, and SEC filing systems is typically required. Exceptional interpersonal, presentation, and networking skills help build trust with investors and effectively convey complex scientific information. These skills are crucial for attracting investment, maintaining regulatory compliance, and supporting the growth of biotech companies.

What are some common challenges faced by freelance biotech investor relations professionals, and how can they be addressed?

Freelance biotech investor relations professionals often face challenges such as staying updated on rapidly evolving scientific developments, building credibility with investors without the backing of a large firm, and managing multiple client accounts simultaneously. To address these, it's important to continuously educate oneself on industry trends, establish strong communication channels with both clients and investors, and leverage digital tools to organize workflow and maintain transparency. Networking within the biotech and finance communities can also help build trust and open up new opportunities.

What is the difference between Freelance Biotech Investor Relations vs Biotech Communications Specialist?

AspectFreelance Biotech Investor RelationsBiotech Communications Specialist
CredentialsBiotech knowledge, investor relations experience, communication skillsBiotech knowledge, communication skills, media relations
Work EnvironmentRemote, freelance, project-basedAgency or in-house, often office-based or remote
Employer & Industry UsageBiotech firms, investors, consulting firmsBiotech companies, PR agencies, media outlets

Freelance Biotech Investor Relations professionals focus on managing relationships with investors, providing financial updates, and supporting funding efforts. Biotech Communications Specialists handle media relations, public messaging, and brand reputation. While both roles require biotech knowledge and communication skills, investor relations is more finance-oriented, whereas communications focus on media and public perception.

More about Freelance Biotech Investor Relations jobs

What cities are hiring for Freelance Biotech Investor Relations jobs?

Cities with the most Freelance Biotech Investor Relations job openings:

What are the most commonly searched types of Biotech Investor Relations jobs?

The most popular types of Biotech Investor Relations jobs are:

What states have the most Freelance Biotech Investor Relations jobs?

States with the most job openings for Freelance Biotech Investor Relations jobs include:

What job categories do people searching Freelance Biotech Investor Relations jobs look for?

The top searched job categories for Freelance Biotech Investor Relations jobs are:

Freelance Biotech Investor Relations jobs near you
Infographic showing various Freelance Biotech Investor Relations job openings in the United States as of August 2026, with employment types broken down into 1% As Needed, 85% Full Time, 12% Part Time, 1% Temporary, and 1% Contract. Highlights an 94% Physical, 2% Hybrid, and 4% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.

Investor Relations & Corp. Communications Mgr.

TG Therapeutics, Inc.

Manhattan, NY • On-site

$80 - $120/hr

Other

Posted 4 days ago

Job description

Title: Investor Relations and Corporate Communications Manager

Location: Manhattan, NY and Remote

If you are interested in the below position, please send your resume tocareers@tgtxinc.com and REFERENCE THE POSITION TITLE within the subject line.

Organizational Overview

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing‑remitting disease, and active secondary progressive disease, as well as approval by several foreign nations for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.TGTherapeutics.com.

Role

TG Therapeutics is seeking a highly motivated and detail‑oriented professional to support both Corporate Communications and Investor Relations initiatives. This individual will play an important role in helping execute strategic communications programs, supporting investor‑facing activities, and ensuring consistent messaging across internal and external stakeholders. This candidate should have strong computer skills and be comfortable working with platforms that will help us monitor both our corporate messaging and investor market intelligence and should understand company modeling.

The ideal candidate is a strong communicator with exceptional organizational skills, intellectual curiosity, and the ability to manage multiple priorities in a fast‑paced public company environment. This role offers the opportunity to gain broad exposure to corporate strategy, executive communications, investor engagement, and commercial‑stage biotechnology operations.

Key Responsibilities
  • Support the development and execution of corporate communications initiatives, including press releases, corporate presentations, internal communications, and social media content.
  • Assist in preparing materials for quarterly earnings calls, investor conferences, analyst and investor meetings, and other investor‑related activities.
  • Assist with the management of analyst modeling
  • Coordinate logistics and communications for investor conferences, events, NDRS etc.
  • Maintain and update corporate communications materials, including website content, fact sheets and executive biographies
  • Help monitor industry news, analyst coverage, competitive activity, and market trends relevant to TG Therapeutics.
  • Assist in managing communication calendars, timelines, approvals, and project coordination.
Professional Experience / Qualifications
  • Approximately 5 or more years of relevant professional experience in corporate communications, investor relations, public relations, healthcare communications, finance, or related fields preferred.
  • Experience within biotechnology, pharmaceutical, healthcare, agency, or public company environments is a plus.
  • Strong written, verbal, and interpersonal communication skills.
  • Excellent organizational skills with strong attention to detail and the ability to manage multiple projects simultaneously.
  • Ability to work effectively in a collaborative, fast‑paced environment.
  • Professional maturity and discretion in handling confidential information.
  • Strong skills with Microsoft Office Suite (particularly PowerPoint and Excel), Outlook, and shared‑drive systems (OneDrive, SharePoint).
  • Experience supporting executive communications, investor relations, public relations, or corporate communications activities preferred.
  • Ability to quickly learn and manage multiple industry monitoring platforms
  • Interest in biotechnology, healthcare, life sciences, or financial communications strongly preferred.
  • Self‑starter with a proactive mindset and willingness to take ownership of projects.
Education
  • Bachelor’s degree required, preferably in Communications, Public Relations, Journalism, Business, Finance, Marketing, Life Sciences, or a related field.

Applicants must be currently authorized to work in the United States on a full‑time basis. The company does not sponsor employment visas for this position.

TG Therapeutics is an equal employment opportunity employer, and does not discriminate on the basis of race, color, religion, gender, sexual orientation, gender identity or expression, age, disability, national origin, ancestry, genetic information, military or veteran status, pregnancy or pregnancy‑related condition or any other protected characteristic.

#J-18808-Ljbffr

Apply